Manufacturer profile

LEICA BIOSYSTEMS NEWCASTLE LTD.

Indonesia·United Kingdom·20 products registered

20

Total Products

20

Product Names

2

Product Classes

2

Risk Classes

Risk classification breakdown

Distribution of products across risk classes

Kelas Resiko : A

19

95.0% of total

Kelas Resiko : B

1

5.0% of total

Product class portfolio

Products organized by product class

Kelas : 119 Products

LEICA BOND Primary Antibody DiluentFeb 10, 2025

Kelas Resiko : A

LEICA BOND™ CD34 (QBEnd/10)Feb 10, 2025

Kelas Resiko : A

LEICA BOND™ bcl-6 (LN22)Feb 10, 2025

Kelas Resiko : A

LEICA NOVOCASTRA IHC DiluentFeb 7, 2025

Kelas Resiko : A

LEICA NOVOCASTRA™ Novolink™ Polymer Detection SystemFeb 7, 2025

Kelas Resiko : A

... and 14 more products in this class

Kelas : 21 Products

LEICA BOND™ CD3 (LN10)Feb 10, 2025

Kelas Resiko : B

Recent registrations (20 most recent)

Most recently registered products with BPOM

LEICA BOND Primary Antibody DiluentFeb 10, 2025

Class: Kelas : 1

Risk Class: Kelas Resiko : A

LEICA BOND™ CD34 (QBEnd/10)Feb 10, 2025

Class: Kelas : 1

Risk Class: Kelas Resiko : A

LEICA BOND™ bcl-6 (LN22)Feb 10, 2025

Class: Kelas : 1

Risk Class: Kelas Resiko : A

LEICA BOND™ CD3 (LN10)Feb 10, 2025

Class: Kelas : 2

Risk Class: Kelas Resiko : B

LEICA NOVOCASTRA IHC DiluentFeb 7, 2025

Class: Kelas : 1

Risk Class: Kelas Resiko : A

LEICA NOVOCASTRA™ Novolink™ Polymer Detection SystemFeb 7, 2025

Class: Kelas : 1

Risk Class: Kelas Resiko : A

LEICA NOVOCASTRA Epitope Retrieval SolutionFeb 6, 2025

Class: Kelas : 1

Risk Class: Kelas Resiko : A

LEICA NOVOCASTRA Epitope Retrieval Solution pH 9 (x10 Concentrate)Feb 6, 2025

Class: Kelas : 1

Risk Class: Kelas Resiko : A

LEICA BOND Ready-To-Use Primary Antibody Kappa Light Chain (CH15)Jun 10, 2024

Class: Kelas : 1

Risk Class: Kelas Resiko : A

LEICA BOND Ready-To-Use Primary Antibody CD79a (JCB117)Jun 7, 2024

Class: Kelas : 1

Risk Class: Kelas Resiko : A

LEICA BOND Ready-To-Use Primary Antibody Napsin A (IP64)Jun 7, 2024

Class: Kelas : 1

Risk Class: Kelas Resiko : A

LEICA BOND Ready-to-Use Primary Antibody S-100 (EP32)Jun 7, 2024

Class: Kelas : 1

Risk Class: Kelas Resiko : A

LEICA BOND Ready-To-Use Primary Antibody B Cell Specific Octamer Binding Protein-1 (TG14)Jun 6, 2024

Class: Kelas : 1

Risk Class: Kelas Resiko : A

LEICA BOND™ Ready-to-Use Primary Antibody c-erbB-2 OncoproteinMar 25, 2024

Class: Kelas : 1

Risk Class: Kelas Resiko : A

LEICA BOND™ Ready-to-Use Primary Antibody MLH1 (Mismatch Repair Protein) (ES05)Mar 22, 2024

Class: Kelas : 1

Risk Class: Kelas Resiko : A

LEICA BOND™ Ready-to-Use Primary Antibody PMS2 (Mismatch Repair Protein) (EP51)Mar 19, 2024

Class: Kelas : 1

Risk Class: Kelas Resiko : A

LEICA BOND™ Ready-to-Use Primary Antibody MSH6 (Mismatch Repair Protein) (EP49)Mar 19, 2024

Class: Kelas : 1

Risk Class: Kelas Resiko : A

LEICA BOND™ Ready-to-Use Primary Antibody MSH2 (Mismatch Repair Protein) (79H11)Mar 19, 2024

Class: Kelas : 1

Risk Class: Kelas Resiko : A

LEICA NOVOCASTRA Liquid Mouse Monoclonal Antibody CD56 (NCAM)Dec 7, 2023

Class: Kelas : 1

Risk Class: Kelas Resiko : A

LEICA BOND CD45 (X16/99)Oct 4, 2023

Class: Kelas : 1

Risk Class: Kelas Resiko : A

About this profile

LEICA BIOSYSTEMS NEWCASTLE LTD. from United Kingdom is a medical device manufacturer with 20 registered products in the Indonesia BPOM database through Pure Global AI's free platform. The company produces 20 unique product types across 2 product classes.

This page provides comprehensive manufacturer intelligence including complete product portfolio, risk class distribution, and product class analysis. Pure Global AI offers free access to 67,600+ Indonesia medical device registrations, helping global MedTech companies identify manufacturers, analyze portfolios, and discover partnership opportunities efficiently.

Free Manufacturer ProfilePowered by Pure Global AI20 Products2 Classes